scispace - formally typeset
W

Wannian Zhang

Researcher at Second Military Medical University

Publications -  171
Citations -  5576

Wannian Zhang is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Camptothecin & Candida albicans. The author has an hindex of 35, co-authored 166 publications receiving 4310 citations. Previous affiliations of Wannian Zhang include Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

Divergent Cascade Construction of Skeletally Diverse “Privileged” Pyrazole‐Derived Molecular Architectures

TL;DR: A powerful divergent cascade strategy has been explored for the easy construction of diverse enantioenriched pyrazole-derived scaffolds from readily available chiral fused pyrazoles-tetrahydropyran acetals, revealing potent anticancer lead compounds that deserve further development.
Journal ArticleDOI

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

TL;DR: A series of novel antifungal triazoles with substituted triazole-piperidine side chains were designed and synthesized and showed good inhibitory activity against a variety of clinically important fungal pathogens.
Journal ArticleDOI

Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.

TL;DR: A series of hybrid molecules designed and synthesized on the basis of 3-amino-10-hydroxylevodiamine and SAHA proved to be a potent inhibitor of topoisomerase I/II and HDAC with good antiproliferative and apoptotic activities.
Journal ArticleDOI

Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review

TL;DR: This review summarizes the recent advances in the medicinal chemistry of small-molecule inhibitors in the areas of drug design, structure-activity relationships, and biological and biochemical properties and concludes that further research is required for the discovery of more potent inhibitors.
Journal ArticleDOI

Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease.

TL;DR: The role of NRF2 in AD and theNRF2 activators advanced into clinical and preclinical studies will be summarzied.